NFG
MRNS

Next Financial Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Next Financial Group’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-668
Closed -$3K – 2346
2016
Q4 		$3K Buy
668
+408
+157% +$1.9K ﹤0.01% 2118
2016
Q3 		$2K Buy
+260
New +$1.76K ﹤0.01% 2199

Other funds holding MRNS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Next Financial Group's MRNS Position: Q1 2017 in Review

Next Financial Group sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2017, closing a stake of 668 shares — an estimated $3K sold.

Next Financial Group first reported a position in MRNS in Q3 2016 and held it in 2 quarters. The position peaked at $3K in Q4 2016. 27 funds tracked by Wall St. Rank hold MRNS as of Q1 2017.

  • Next Financial Group reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2017 after selling out during the quarter.
  • Next Financial Group sold 668 Marinus Pharmaceuticals, Inc shares in Q1 2017, an estimated $3K.
  • Next Financial Group first reported a position in Marinus Pharmaceuticals, Inc in Q3 2016 and held it in 2 quarters.
  • Next Financial Group's Marinus Pharmaceuticals, Inc position peaked at $3K in Q4 2016.
  • 27 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2017.

Based on Next Financial Group's 13F filing for Q1 2017, filed 8 May 2017.